Scientists have created a fluorescent probe that can tag and illuminate single specimens of the bacteria that cause tuberculosis (TB), one of the world's most problematic infectious diseases. The probe, along with a microfluidic chip that counts TB bacteria, could find applications in fields ranging from diagnosis of TB to assessing the effectiveness of novel therapies.
TB, caused by the bacterium Mycobacterium tuberculosis (Mtb), is a highly contagious disease that infects the lungs and causes chronic coughs, fever, and weight loss. The disease is a massive burden on health systems worldwide, costing the world over $21 billion a year and being responsible for approximately two million deaths annually. Efforts to rein in the malady have been hindered by the HIV epidemic, the spread of antibiotic resistance and the fact that the most common diagnostic techniques for TB are decades old. The bacteria can develop antibiotic resistance in part due to the presence of an enzyme named BlaC that breaks down the structure of many common antibiotics.
A team led by Yunfeng Cheng exploited this apparent strength by designing a molecule that is activated by BlaC and attaches to another enzyme named DprE1. The probe, named CDG-DNB3, produces a bright green color within one hour after activation by BlaC, allowing for rapid labeling of both single and multiple Mtb bacteria. The authors tested the probe in a weakened variant of TB named BCG and found the probe could distinguish between live bacteria and dead bacteria, as well as between BCG and 43 related nontuberculosis mycobacterial species.
Chang et al. also created a chip using microfluidics technology that accurately counted bacteria within BCG samples labeled with CDG-DNB3 as they passed through a detection window.
Source: American Association for the Advancement of Science
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.